Ultra Nasdaq Biotechnology Proshares (BIB) 42.07

New Post Public Reply Private Reply Replies (0) Message Board

Mar 6, 2016 at 2:55 AM

Ultra Nasdaq Biotechnology Proshares (BIB) 42.07 $BIB

The 2016 Market's 2-Month Checkup
Greg Wajda - at Seeking Alpha - Wed Mar 02, 11:08AM CST

USO: 9.65 (+0.40), ABX: 13.72 (-0.19), BIB: 42.07 (-0.31), GOLD: 91.01 (+1.09), NEM: 26.11 (-0.71), BAC: 13.54 (+0.04), WFC: 50.11 (+0.34), GDXJ: 27.11 (-0.26), USB: 41.03 (+0.26), FNV: 57.26 (-0.45), GLD: 120.54 (-0.19), OIL: 5.17 (+0.20), IAU: 12.17 (unch), GDX: 19.71 (-0.11)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 33.7% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Feb 05, 5:44PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 33.67% as of today's recent price of $40.16.
BIB: 42.07 (-0.31)

Downtrend Call Working As ProShares Ultra Nasdaq Biotechnology ETF Stock Falls 30.1% (BIB)
Comtex SmarTrend(R) - Fri Jan 29, 5:04PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 3 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 30.07% as of today's recent price of $42.34.
BIB: 42.07 (-0.31)

BUYINS.NET: FXR, XIN, PRIM, HIL, MVV, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Jan 25, 6:25AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Industrials/Producer Drbls AlphaDEX Fd (NYSE:FXR), iShares MSCI EAFE Index (CAD-Hedged) (NYSE:XIN), PRIMORIS SERVICES CORPORATION (NASDAQ

RIM), Hill International Inc (NYSE:HIL), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
HIL: 3.72 (-0.02), PRIM: 22.81 (+0.28), MVV: 67.46 (+0.88), BIB: 42.07 (-0.31), XIN: 3.95 (-0.02), FXR: 26.74 (+0.12)

ProShares Ultra Nasdaq Biotechnology ETF Has Returned 18.5% Since SmarTrend Recommendation (BIB)
Comtex SmarTrend(R) - Fri Jan 22, 12:48PM CST
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on January 7th, 2016 at $60.55. In approximately 2 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 18.46% as of today's recent price of $49.37.
BIB: 42.07 (-0.31)

BUYINS.NET: NOG, HTHT, BIB, KKR, HBM, JMP Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Dec 18, 6:51AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Nordic Oil and Gas Ltd (NYSE:NOG), China Lodging Group Ltd (NASDAQ:HTHT), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), KKR & Co. L.P. (NYSE:KKR), HudBay Minerals Inc (NYSE:HBM), JMP Group Inc (NYSE:JMP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
NOG: 5.00 (+0.61), JMP: 5.12 (-0.01), BIB: 42.07 (-0.31), HBM: 4.15 (+0.31), KKR: 13.42 (+0.44), HTHT: 30.10 (+1.24)

BUYINS.NET: DFT, JKL, IYT, BIB, KKR, NOAH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 02, 8:25PM CST
November 20, 2015
NOAH: 24.02 (+0.25), DFT: 36.13 (+0.05), BIB: 42.07 (-0.31), JKL: 115.55 (+1.28), KKR: 13.42 (+0.44), IYT: 137.53 (+0.92)

SmarTrend Watching for Potential Pullback in Shares of ProShares Ultra Nasdaq Biotechnology ETF After 2.04% Gain
Comtex SmarTrend(R) - Wed Nov 25, 5:25PM CST
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $70.60 to a high of $72.42. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $72.09 on volume of 493,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 42.07 (-0.31)

After Yesterday's Rally of 1.01% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 26, 5:37PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $61.23 to a high of $65.61. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $63.25 on volume of 1.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 42.07 (-0.31)

BUYINS.NET: NEPT, SBH, AIMC, CVLT, MHH, BIB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 23, 8:02AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Neptun SA (NASDAQ:NEPT), Sally Beauty Holdings Inc (NYSE:SBH), Altra Holdings Inc (NASDAQ:AIMC), CommVault Systems Inc (NASDAQ:CVLT), Mastech Holdings Inc (NYSE:MHH), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
BIB: 42.07 (-0.31), SBH: 31.32 (-0.18), MHH: 7.77 (+0.14), CVLT: 38.64 (+0.28), AIMC: 25.07 (+0.04), NEPT: 1.09 (+0.01)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Pullback After Yesterday's Rally of 1.04%
Comtex SmarTrend(R) - Mon Oct 19, 4:45PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $60.36 to a high of $65.30. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $64.21 on volume of 2.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BIB: 42.07 (-0.31)

ProShares Ultra Nasdaq Biotechnology ETF Down 6.7% Since SmarTrend Downtrend Call (BIB)
Comtex SmarTrend(R) - Mon Oct 19, 10:15AM CDT
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on September 24th, 2015 at $68.46. In approximately 4 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 6.71% as of today's recent price of $63.86.
BIB: 42.07 (-0.31)

ProShares Ultra Nasdaq Biotechnology ETF Down 13.2% Since SmarTrend Downtrend Call (BIB)
Comtex SmarTrend(R) - Fri Oct 09, 10:07AM CDT
SmarTrend identified a Downtrend for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) on September 24th, 2015 at $68.46. In approximately 2 weeks, ProShares Ultra Nasdaq Biotechnology ETF has returned 13.15% as of today's recent price of $59.45.
BIB: 42.07 (-0.31)

Watch for ProShares Ultra Nasdaq Biotechnology ETF to Potentially Rebound After Falling 7.24% Yesterday
Comtex SmarTrend(R) - Tue Oct 06, 5:07PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $54.30 to a high of $61.24. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $56.25 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 42.07 (-0.31)

Guide to Inverse & Leveraged Biotech ETF Investing
Zacks Equity Research - Zacks Investment Research - Fri Sep 25, 11:08AM CDT
Understanding the basics of investing in the inverse and leveraged biotech ETFs, depending on market conditions.
BIS: 43.90 (+0.49), BIB: 42.07 (-0.31), UBIO: 25.04 (-0.28), LABU: 7.37 (+0.13), LABD: 57.97 (-0.93), ZBIO: 37.06 (+0.49)

ProShares Ultra Nasdaq Biotechnology ETF Set to Possibly Rebound After Yesterday's Selloff of 8.82%
Comtex SmarTrend(R) - Mon Sep 21, 4:35PM CDT
ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) traded in a range yesterday that spanned from a low of $73.40 to a high of $83.54. Yesterday, the shares fell 8.8%, which took the trading range below the 3-day low of $79.97 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BIB: 42.07 (-0.31)

BUYINS.NET: TQQQ, FNGN, BIB, PLOW, RLOC, AOR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Sep 03, 6:37AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Trust UltraPro QQQ ETF (NASDAQ:TQQQ), Financial Engines Inc (NASDAQ:FNGN), ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Douglas Dynamics Inc (NYSE

LOW), REACHLOCAL INCORPORATION (NASDAQ:RLOC), iShares S&P Growth Allocation ETF (NYSE:AOR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
FNGN: 27.72 (+0.70), BIB: 42.07 (-0.31), PLOW: 21.04 (+0.16), RLOC: 1.63 (+0.03), TQQQ: 92.49 (+0.16), AOR: 38.59 (+0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

MiniCo's New Desk: A Game Changer for E&S Market

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Concrete Pipe: Foundation of Modern Infrastructure

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Maternal Health Index: A New Tool With Big Ambitions

A Fresh Take on Maternal Health Today's all about the Heartland Forward's fresh tool, the Maternal Resiliency Index. It's making a splash at the 2026 Heartland Summit with a lot of promise on its shoulders. Backed by economists and health gurus like Emily Oster and Dr. Neel Shah, this index ain't your run-of-the-mill tool. It's here to shake the couch coins out of...

Ultrabench Revolutionizes AI Model Comparison Game

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Cannatrol and Veterans Nonprofit Unite for Healing

Veterans Find a New Ally in Cannabis Tech When two distinct worlds collide for a cause, it can create waves of change much bigger than simple collaboration. That's exactly what's happening with Cannatrol and Operation Green Healing, a partnership that could redefine support for our veterans. Cannatrol, renowned for its groundbreaking post-harvest cannabis technology, has...

Athlete Threats: Public Info Fuels Security Risks

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Haystack MRD Shines in Colorectal Cancer Trials

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Nukleus Launches Unified Platform for Athletes' Business

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...

Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...